WOS: 000317860700016PubMed ID: 23900530This is the case report of a pregnant woman who refused pregnancy termination when diagnosed with pulmonary arterial hypertension (PAH) functional class 2-3 at the 24th week of gestation and of her newborn. A pregnant woman with PAH functional class 2-3 was treated with inhaled prostacyclin analog ( iloprost), oral sildenafil, oxygen, and low molecular weight heparin. She delivered at 32nd week by Cesarean section. The infant required oxygen up to 36th week postconceptional age and had a short steroid treatment. The mother needed close cardiovascular monitorization, intensive oxygen and pulmonary vasodilator therapy for 2 months and was discharged with oxygen and oral iloprost treatment. A multidiscipl...
The mortality of pulmonary hypertension that complicates pregnancy is very high. The increased pulmo...
Pulmonary hypertension is defined as an increase in mean pulmonary arterial pressure (mPAP) ≥25 mmHg...
Previous studies have reported mortality rates of up to 56% associated with pregnancy in pulmonary a...
WOS: 000317860700016PubMed ID: 23900530This is the case report of a pregnant woman who refused pregn...
Pulmonary arterial hypertension (PAH) is a rare and devastating disease characterized by progressive...
Purpose: The purpose of our study is to show that women with pulmonary arterial hypertension (PAH) w...
AbstractWe describe a case of a 25-year-old pregnant woman who presented with severe primary pulmona...
Pulmonary arterial hypertension (PAH) is characterized by pulmonary vascular remodeling that limits ...
Background: Pulmonary hypertension (PH) is a rare cardiovascular disorder that leads to right heart ...
Chronic thromboembolic pulmonary hypertension (CTEPH) is a subset of pulmonary hypertension caused b...
Background - Pulmonary arterial hypertension carries a high risk of mortality in pregnancy. Recent a...
Introduction: Since pregnancy in women with pulmonary arterial hypertension (PAH) is associated with...
Current guidelines do not recommend pregnancy in patients with pulmonary arterial hypertension (PAH)...
To describe the outcomes of pregnancy in women with pulmonary hypertension. In 2007 the European Reg...
Despite advanced therapies, maternal mortality in women with pulmonary arterial hypertension (PAH) r...
The mortality of pulmonary hypertension that complicates pregnancy is very high. The increased pulmo...
Pulmonary hypertension is defined as an increase in mean pulmonary arterial pressure (mPAP) ≥25 mmHg...
Previous studies have reported mortality rates of up to 56% associated with pregnancy in pulmonary a...
WOS: 000317860700016PubMed ID: 23900530This is the case report of a pregnant woman who refused pregn...
Pulmonary arterial hypertension (PAH) is a rare and devastating disease characterized by progressive...
Purpose: The purpose of our study is to show that women with pulmonary arterial hypertension (PAH) w...
AbstractWe describe a case of a 25-year-old pregnant woman who presented with severe primary pulmona...
Pulmonary arterial hypertension (PAH) is characterized by pulmonary vascular remodeling that limits ...
Background: Pulmonary hypertension (PH) is a rare cardiovascular disorder that leads to right heart ...
Chronic thromboembolic pulmonary hypertension (CTEPH) is a subset of pulmonary hypertension caused b...
Background - Pulmonary arterial hypertension carries a high risk of mortality in pregnancy. Recent a...
Introduction: Since pregnancy in women with pulmonary arterial hypertension (PAH) is associated with...
Current guidelines do not recommend pregnancy in patients with pulmonary arterial hypertension (PAH)...
To describe the outcomes of pregnancy in women with pulmonary hypertension. In 2007 the European Reg...
Despite advanced therapies, maternal mortality in women with pulmonary arterial hypertension (PAH) r...
The mortality of pulmonary hypertension that complicates pregnancy is very high. The increased pulmo...
Pulmonary hypertension is defined as an increase in mean pulmonary arterial pressure (mPAP) ≥25 mmHg...
Previous studies have reported mortality rates of up to 56% associated with pregnancy in pulmonary a...